Responses
Immunotherapy biomarkers
Original research
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
